These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2573328)

  • 1. P3 in schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms.
    Pfefferbaum A; Ford JM; White PM; Roth WT
    Arch Gen Psychiatry; 1989 Nov; 46(11):1035-44. PubMed ID: 2573328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERPs in schizophrenia: effects of antipsychotic medication.
    Ford JM; White PM; Csernansky JG; Faustman WO; Roth WT; Pfefferbaum A
    Biol Psychiatry; 1994 Aug; 36(3):153-70. PubMed ID: 7948453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics.
    Roth WT; Goodale J; Pfefferbaum A
    Biol Psychiatry; 1991 Mar; 29(6):585-99. PubMed ID: 1675890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N2 and P3 components of event-related potential in first-episode schizophrenic patients: scalp topography, medication, and latency effects.
    Demiralp T; Uçok A; Devrim M; Isoglu-Alkaç U; Tecer A; Polich J
    Psychiatry Res; 2002 Aug; 111(2-3):167-79. PubMed ID: 12374634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study.
    Mathalon DH; Ford JM; Pfefferbaum A
    Biol Psychiatry; 2000 Mar; 47(5):434-49. PubMed ID: 10704955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric manipulations of auditory stimuli differentially affect P3 amplitude in schizophrenics and controls.
    Salisbury DF; O'Donnell BF; McCarley RW; Nestor PG; Faux SF; Smith RS
    Psychophysiology; 1994 Jan; 31(1):29-36. PubMed ID: 8146252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.
    Kathmann N; Wagner M; Rendtorff N; Engel RR
    Biol Psychiatry; 1995 May; 37(10):754-7. PubMed ID: 7640331
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventricle size and P300 in schizophrenia.
    Juckel G; Reischies FM; Müller-Schubert A; Vogel AC; Gaebel W; Hegerl U
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):352-4. PubMed ID: 8043621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.
    Javitt DC; Doneshka P; Grochowski S; Ritter W
    Arch Gen Psychiatry; 1995 Jul; 52(7):550-8. PubMed ID: 7598631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in P3 amplitudes between schizophrenics and healthy controls vary between the different events presented in a guessing task.
    Verleger R; Bode M; Arolt V; Wascher E; Kömpf D
    Neuropsychobiology; 1994; 30(2-3):114-23. PubMed ID: 7800157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Event-related potentials in schizophrenics.
    Roth WT; Horvath TB; Pfefferbaum A; Kopell BS
    Electroencephalogr Clin Neurophysiol; 1980 Feb; 48(2):127-39. PubMed ID: 6153330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and P3 amplitude enhancement in schizophrenia following feedback training.
    Fukuda M; Niwa S; Hiramatsu K; Hata A; Saitoh O; Hayashida S; Nakagome K; Iwanami A; Sasaki T; Honda H; Itoh K
    Schizophr Res; 1997 Jun; 25(3):231-42. PubMed ID: 9264178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of specificity of a visual P3 amplitude modulation deficit in schizophrenia.
    Neuhaus AH; Trempler NR; Hahn E; Luborzewski A; Karl C; Hahn C; Opgen-Rhein C; Urbanek C; Schaub R; Dettling M
    Schizophr Res; 2010 Dec; 124(1-3):119-26. PubMed ID: 20805022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual P3 amplitude modulation deficit in schizophrenia is independent of duration of illness.
    Neuhaus AH; Hahn E; Hahn C; Ta TM; Opgen-Rhein C; Urbanek C; Dettling M
    Schizophr Res; 2011 Aug; 130(1-3):210-5. PubMed ID: 21382693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain potential evidence for an auditory sensory memory deficit in schizophrenia.
    Catts SV; Shelley AM; Ward PB; Liebert B; McConaghy N; Andrews S; Michie PT
    Am J Psychiatry; 1995 Feb; 152(2):213-9. PubMed ID: 7840354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication.
    Coburn KL; Shillcutt SD; Tucker KA; Estes KM; Brin FB; Merai P; Moore NC
    Biol Psychiatry; 1998 Sep; 44(6):466-74. PubMed ID: 9777178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed visual NA potential in remitted schizophrenia: a new vulnerability marker for psychotic relapse under low-dose medication.
    Matsuoka H; Matsumoto K; Yamazaki H; Yoshida S; Numachi Y; Saito H; Ueno T; Sato M
    Biol Psychiatry; 1999 Jan; 45(1):107-15. PubMed ID: 9894582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N1 component derived from the temporal region during an auditory passive event-related potential paradigm in schizophrenics.
    Iwanami A; Suga I; Kanamori R
    Clin Electroencephalogr; 1994 Apr; 25(2):50-3. PubMed ID: 8194187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P300 abnormality in schizophrenic subtypes.
    St Clair D; Blackwood D; Muir W
    J Psychiatr Res; 1989; 23(1):49-55. PubMed ID: 2569037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.